Tag: Rimegepant

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Rimegepant

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Surges to Record High

Added to Collection on: 2019-03-03 00:08:12

Tags for this article:

Blogs
Seeking Alpha
Drugs
AYX
Biohaven Pharmaceutical Holding Company Ltd.
Chemical compounds
Organic compounds
Carbamates
Riluzole
Rimegepant

Click the tags to see associated articles and topics

View Article Details
EPS for Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Expected At $-1.80

Added to Collection on: 2019-05-09 20:32:25

Tags for this article:

Chemical compounds
Organic compounds
AYX
CoV
New York Stock Exchange
Rimegepant
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Rimegepant Bests Placebo for Preventing Migraine

Added to Collection on: 2020-12-21 16:15:30

Tags for this article:

Clinical research
Mind?body interventions
Migraine
Placebo
Medicine
Clinical medicine
Health
Monoclonal antibodies
Migraine treatment
Prevention of migraines
Rimegepant

Click the tags to see associated articles and topics

View Article Details
Biohaven Highlights Neuroscience Advancements with 22 Presentations at the 2021 American ...

Added to Collection on: 2021-04-13 11:26:15

Tags for this article:

Calcitonin gene-related peptide receptor antagonists
Chemical compounds
Migraine
Carbamates
Organic compounds
Piperidines
Branches of biology
Rimegepant
CALCRL
Calcitonin gene-related peptide
Neurogenic inflammation
Biohaven Pharmaceutical Holding Company Ltd.

Click the tags to see associated articles and topics

View Article Details
Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to ...

Added to Collection on: 2021-06-15 10:50:00

Tags for this article:

Monoclonal antibodies
Migraine
Health care
Calcitonin gene-related peptide receptor antagonists
Life Sciences
Clinical medicine
Calcitonin gene-related peptide
Neuropeptides
Galcanezumab
Prevention of migraines
Erenumab
Rimegepant
Eli Lilly
Biohaven Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Lilly Launches Head-to-Head Trial in Quest to Bolster Migraine Preventive Drug

Added to Collection on: 2021-06-15 16:30:00

Tags for this article:

Monoclonal antibodies
Calcitonin gene-related peptide receptor antagonists
Life Sciences
Health care
Drugs
Breakthrough therapy
Galcanezumab
Calcitonin gene-related peptide
Erenumab
Migraine
Teva Pharmaceuticals
Rimegepant
Eli Lilly
Eli Lilly and Company

Click the tags to see associated articles and topics

View Article Details
Primary Care Primer for Headache Management, with Morris Levin, MD

Added to Collection on: 2025-04-09 11:47:40

Tags for this article:

Monoclonal antibodies
Headaches
Migraine
Calcitonin gene-related peptide receptor antagonist
Calcitonin gene-related peptide
Pain management
Management of migraine
Headache
Galcanezumab
Cluster headache
Rimegepant
Sumatriptan

Click the tags to see associated articles and topics

View Article Details
Migraine Treatment Market Outlook 2025–2035 | Trends, Dynamics, and North America Insights

Added to Collection on: 2025-08-21 10:59:07

Tags for this article:

Migraine
Calcitonin gene-related peptide receptor antagonists
Piperidines
Medicinal chemistry
Therapy
Management of migraine
Calcitonin gene-related peptide
Triptan
Rimegepant
Medication overuse headache
Telehealth
Vagus nerve stimulation
United States

Click the tags to see associated articles and topics

View Article Details
Biohaven's rare disease drug is 'ready to ship on Day 1' following FDA approval

Added to Collection on: 2025-09-04 17:25:09

Tags for this article:

Rare diseases
Autosomal dominant disorders
Spinocerebellar ataxia
Rimegepant
Migraine
AbbVie
Cerebellar ataxia
Ataxia
Pfizer

Click the tags to see associated articles and topics

View Article Details
Book a Demo